查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
青霉素市场 - 全球行业规模、份额、趋势、机会和预测，2018-2028 年，按产品、按类型、按管理途径、按最终用户、按地区、竞争
市场调查报告书
商品编码
1255231

青霉素市场 - 全球行业规模、份额、趋势、机会和预测，2018-2028 年，按产品、按类型、按管理途径、按最终用户、按地区、竞争

Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product, By Type, By Route of Administration, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球青霉素市场预计在预测期内将出现显着增长。

这可能与下呼吸道感染、疟疾、肺结核等传染病高发有关。 2020年，非洲是每10万人结核病发病率最高的地区。 患病率约为 220。 同样，美洲报告每 100,000 人中大约有 29 例新结核病病例。 此外，世界各地的政府机构、製药和生物技术公司加大力度和投资开发新型抗生素，也显着增加了全球对青霉素的需求。 此外，医疗保健领域越来越多地采用新药正在推动全球青霉素市场的增长。 此外，对新疗法的认识不断提高将在未来几年进一步增加对青霉素的需求，从而支持市场的增长。

各类传染病的传播

细菌感染的频率与日俱增。 细菌感染增加的主要原因是卫生条件差，饭前做饭前不洗手，打喷嚏不遮盖，卫生习惯差。 这大大增加了对抗生素的需求，从而在预测期内为青霉素市场提供了有利可图的增长机会。 2021 年，意大利每日处方抗生素消费量约为每 1,000 人 13 剂。 同样，在以公共交通为主要通讯方式的低收入和中等收入国家，大多数细菌感染的传播都是通过公共交通传播的，从而增加了对抗生素和青霉素的需求。市场增长机会正在显现创建。

扩大研发活动

细菌中抗生素耐药性的增加和各种传染性细菌感染的流行正在推动生物技术和製药公司开发新的和先进的治疗方法和产品。 因此，有望为青霉素市场的增长创造新的前景。 根据 clinicaltrials.gov 的数据，大约有 93 项与青霉素相关的临床试验，分阶段进行。 同样，新药审批流程的改进也有望推动多年来的市场增长。 2020年，默克（Merck）公司获得美国 FDA 对 RECARBRIO 额外新药申请的审查批准，用于 HABP/VABP 。 日益加重的传染病负担迫使政府和非政府组织投资研发活动，进一步推动新抗生素的开发，并为新药开发设定新方向。

近期发展

  • 2022 8 月，PAION AG 在德国推出了 XERAVA（eravacycline），用于治疗成人復杂性腹腔内感染 (cIAI)。
  • 2021 年 10 月，GSK 的头孢类抗生素分公司被诺华收购。 如今，凭藉在 100 多个市场独家拥有三个知名品牌，我们已成为世界领先的抗生素製造商。

可自定义

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势

第 4 章 VOC（客户之声）

第5章临床试验分析

  • 正在进行的临床试验
  • 已完成临床试验
  • 已完成临床试验
  • 管道细分，按开发阶段
  • 管道细分，按状态
  • 按研究类型划分的管道细分
  • 按地区划分的渠道细分
  • 临床试验热图

第六章全球青霉素市场展望

  • 市场规模和预测
    • 按金额/数量
  • 市场份额和预测
    • 按产品（散装、配药）
    • 按类型（氨基青霉素、抗菌青霉素、β-内□胺□抑製剂等）
    • 通过给药途径（口服、肌肉注射、静脉注射）
    • 最终用户（医院/诊所、製药/生物技术公司、学术/研究机构）
    • 按地区（北美、欧洲、亚太地区、南美、中东/非洲）
    • 按公司分类（2022 年）
  • 市场地图
    • 按产品分类
    • 通过使用
    • 按技术
    • 按原材料
    • 按地区

第七章北美青霉素市场展望

  • 市场规模和预测
    • 按金额/数量
  • 市场份额和预测
    • 按产品分类
    • 按类型
    • 按给药途径
    • 最终用户
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 加拿大
    • 墨西哥

第八章欧洲青霉素市场展望

  • 市场规模和预测
    • 按金额/数量
  • 市场份额和预测
    • 按产品分类
    • 按类型
    • 按给药途径
    • 最终用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第9章亚太青霉素市场展望

  • 市场规模和预测
    • 按金额/数量
  • 市场份额和预测
    • 按产品分类
    • 按类型
    • 按给药途径
    • 最终用户
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章南美青霉素市场展望

  • 市场规模和预测
    • 按金额/数量
  • 市场份额和预测
    • 按产品分类
    • 按类型
    • 按给药途径
    • 最终用户
    • 按国家
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章中东和非洲青霉素市场展望

  • 市场规模和预测
    • 按金额/数量
  • 市场份额和预测
    • 按产品分类
    • 按类型
    • 按给药途径
    • 最终用户
    • 按国家
  • MEA：国家分析
    • 南非青霉素
    • 沙特阿拉伯的青霉素
    • 阿联酋青霉素

第 12 章市场动态

  • 主持人
    • 传染病的传播
    • 启动研发活动
    • 政府政策和举措
  • 任务
    • 抗菌素耐药性的发展
    • 严格的监管场景

第13章市场趋势与发展

  • 近期趋势
  • 併购
  • 产品公告

第 14 章全球青霉素市场：SWOT 分析

第15章竞争格局

  • Astellas Pharma Inc.
  • Novartis International AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Merck Co. & Inc.
  • F.Hoffmann-La Roche Ltd.
  • Toyama Chemical Co., Ltd.
  • Sanofi Aventis SA
  • MiddleBrook Pharmaceuticals, Inc.
  • Gilead Sciences Inc.

第 16 章战略建议

简介目录
Product Code: 14275

The global penicillin market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the high prevalence of infectious diseases such as lower respiratory infections, malaria, and tuberculosis, among others. In 2020, Africa had the highest prevalence of tuberculosis incidence per 100 000 population. The incidence rate was about 220. Similarly, the Americas reported some 29 new cases of tuberculosis per 100,000 inhabitants. Additionally, growing initiatives and investments by government organizations and pharmaceutical & biotechnology companies across the globe for developing novel antibiotics have significantly increased the demand for penicillin worldwide. Additionally, the growing adoption of new drugs in the healthcare sector has significantly increased, thereby supporting the growth of global penicillin market. Besides, increasing awareness about novel treatments will further increase the demand for penicillin in the coming years, thereby supporting market growth.

Growing Prevalence of Various Types of Infections

Every day the frequency of bacterial infections is increasing. The main reason for increasing bacterial infection is not maintaining proper health, not washing hands before eating or cooking, sneezing without covering, and poor sanitation and hygiene practices. This has significantly increased the demand for antibiotics, thereby creating lucrative growth opportunities for the penicillin market during the forecast period. In 2021, the daily defined dose of antibiotics consumption in Italy was around 13 per 1,000 inhabitants. Similarly, in low and middle-income countries, public transport is the main source of communication, and most of the spread of bacterial infections is being witnessed due to the use of public transport, thereby increasing the demand for antibiotics and creating opportunities for the growth of the penicillin market.

Expanding Research & Development Activities

The growing incidence of antibiotic resistance in bacteria and the increasing prevalence of various communicable bacterial infections have made biotechnology and pharmaceutical companies focus on developing new and advanced therapies and products. This, in turn, is expected to create new prospects for the growth of the penicillin market. According to clinicaltrials.gov, there are around 93 clinical trials related to penicillin that are under different phases. Similarly, betterment in the new drug approval process is expected to boost market growth over the years. In 2020, Merck received an acceptance for a review of a supplemental new drug application from the U.S. FDA for RECARBRIO intended for HABP/VABP. The growing burden of infectious diseases is compelling government and non-government organizations to invest in research and development activities that will further boost the development of novel antibiotics and create new policies for the development of new drugs.

Market Segmentation

The global penicillin market can be segmented by product, type, route of administration, end-user, and by region. Based on the product, the market can be divided into Bulk and Dosage. Based on type, the market can be segmented into Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, and Others. Based on the route of administration, the market can be differentiated into Oral, Intramuscular, and Intravenous. Based on end users, the market can be grouped into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutions. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among the different countries, the United States dominated the global penicillin market on account of the increasing prevalence of infectious in the country. According to the Centers for Disease Control and Prevention, the number of visits to physician offices for infectious and parasitic diseases is around 7.2 million.

Recent Developments

  • In August 2022, PAION AG launched XERAVA (eravacycline), in Germany, for the treatment of complicated intra-abdominal infections (cIAI) in adults.
  • In October 2021, the Cephalosporin antibiotics branch of GSK was purchased by Novartis. It is currently the exclusive owner of three well-known brands in more than 100 markets, establishing its position as the top manufacturer of antibiotics across the globe.

Market Players

Astellas Pharma Inc., Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Merck Co. & Inc., F.Hoffmann-La Roche Ltd., Toyama Chemical Co., Ltd., Sanofi Aventis SA, MiddleBrook Pharmaceuticals, Inc., Gilead Sciences Inc. are some of the leading players operating in the Global Penicillin Market.

Report Scope

In this report, global penicillin market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Penicillin Market, By Product:

  • Bulk
  • Dosage

Penicillin Market, By Type:

  • Aminopenicillin
  • Antipseudomonal Penicillin
  • Beta Lactamase Inhibitor
  • Others

Penicillin Market, By Route of Administration:

  • Oral
  • Intramuscular
  • Intravenous

Penicillin Market, By Route of End User:

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions

Penicillin Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Penicillin Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Penicillin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Bulk, Dosage)
    • 6.2.2. By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others)
    • 6.2.3. By Route of Administration (Oral, Intramuscular, Intravenous)
    • 6.2.4. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions)
    • 6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 6.2.6. By Company (2022)
  • 6.3. Market Map
    • 6.3.1. By Product
    • 6.3.2. By Application
    • 6.3.3. By Technique
    • 6.3.4. By Source
    • 6.3.5. By Region

7. North America Penicillin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By Route of Administration
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Penicillin Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Penicillin Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Penicillin Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By End User

8. Europe Penicillin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Route of Administration
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Penicillin Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Penicillin Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Penicillin Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Penicillin Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Route of Administration
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Penicillin Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Route of Administration
        • 8.3.5.2.4. By End User

9. Asia-Pacific Penicillin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Route of Administration
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Penicillin Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By End User
    • 9.3.2. India Penicillin Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Penicillin Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Penicillin Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value & Volume
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Type
        • 9.3.4.2.3. By Route of Administration
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Penicillin Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value & Volume
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Type
        • 9.3.5.2.3. By Route of Administration
        • 9.3.5.2.4. By End User

10. South America Penicillin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By Route of Administration
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Penicillin Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Penicillin Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Penicillin Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By End User

11. Middle East and Africa Penicillin Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Type
    • 11.2.3. By Route of Administration
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Penicillin Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value & Volume
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Type
        • 11.3.1.2.3. By Route of Administration
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Penicillin Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value & Volume
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Type
        • 11.3.2.2.3. By Route of Administration
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Penicillin Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value & Volume
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Type
        • 11.3.3.2.3. By Route of Administration
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
    • 12.1.1. Growing Prevalence of Infectious Diseases
    • 12.1.2. Rise in Research & Development Activities
    • 12.1.3. Supportive Government Policies & Initiatives
  • 12.2. Challenges
    • 12.2.1. Development of Antibacterial Resistance
    • 12.2.2. Stringent Regulatory Scenario

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Penicillin Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
    • 15.5.1. Astellas Pharma Inc.
    • 15.5.2. Novartis International AG
    • 15.5.3. GlaxoSmithKline plc
    • 15.5.4. Pfizer Inc.
    • 15.5.5. Merck Co. & Inc.
    • 15.5.6. F.Hoffmann-La Roche Ltd.
    • 15.5.7. Toyama Chemical Co., Ltd.
    • 15.5.8. Sanofi Aventis SA
    • 15.5.9. MiddleBrook Pharmaceuticals, Inc.
    • 15.5.10. Gilead Sciences Inc.

16. Strategic Recommendations